JH
Jennifer Scarlet Haas

Well Cited

25
Works
245
Citations
9
H-Index
Search Authors
Author Statistics
External Links
OpenAlex Profile ORCID Profile

Jennifer Scarlet Haas

Also known as: J Haas, J.S. Haas, Jennifer Haas, Jennifer S Haas, Jennifer S. Haas

25

Total Works

245

Citations

9

H-Index

7

i10-Index

Citation & Works Trend by Year
12 years active
Top Research Topics
Liver Disease Diagnosis and Treatment (8) Liver Diseases and Immunity (8) Health Systems, Economic Evaluations, Quality of Life (5) Alcohol Consumption and Health Effects (4) Inflammatory Bowel Disease (3)
Recent Publications
15 shown
Year Publication Title Citations Action
2026 Supplementary materials: Understanding the economic and healthcare burden of metabolic dysfunction-associated steatohepatitis: a real-world claims data analysis from Germany Figshare 0
2026 Understanding the economic and healthcare burden of metabolic dysfunction-associated steatohepatitis: a real-world claims data analysis from Germany Journal of Comparative Effectiveness Research 0
2025 Metabolic Dysfunction–Associated Steatohepatitis Diagnosis and Management in Germany: Insights From an Expert Consensus Panel Liver International 15
2025 FRI-026 Metabolic dysfunction-associated steatohepatitis (MASH) prevalence in germany – results from a claims analysis Journal of Hepatology 0
2024 The impact of anti-inflammatory therapy on Parkinson's disease incidence: A retrospective cohort study Parkinsonism & Related Disorders 9
2024 Association of Anti-inflammatory Therapy Use with the Incidence of Parkinson’s Disease: A Person-Time Analysis Among Patients with Autoimmune Diseases (S2.003) Neurology 0
2023 Real-world treatment persistence in patients with rheumatoid arthritis initiating DMARDs in Germany—a health insurance claims data analysis Zeitschrift für Rheumatologie 3
2021 Real-world Patient characteristics, Treatment Patterns and Costs in Relapsing Multiple Sclerosis Patients Treated With Glatiramer acetate, Dimethyl Fumarate Or Teriflunomide in Germany Neurodegenerative Disease Management 2
2021 Safety and Persistence of Nalmefene Treatment for Alcohol Dependence. Results from Two Post-authorisation Safety Studies Alcohol and Alcoholism 9
2021 Healthcare resource utilization and costs among nonalcoholic fatty liver disease patients in Germany Annals of Translational Medicine 23
2020 Patterns and predictors of mortality and disease progression among patients with non‐alcoholic fatty liver disease Alimentary Pharmacology & Therapeutics 56
2020 The burden of hyperkalemia in Germany – a real world evidence study assessing the treatment and costs of hyperkalemia BMC Nephrology 10
2019 SP348A COMPARATIVE HEALTHCARE COST ANALYSIS OF PATIENTS WITH NON-DIALYSIS CHRONIC KIDNEY DISEASE AND IRON DEFICIENCY/ANEMIA TREATED WITH ORAL OR INTRAVENOUS IRON USING A GERMAN CLAIMS DATABASE Nephrology Dialysis Transplantation 0
2019 PS-060-Increasing risk of disease progression and mortality in nonalcoholic fatty liver disease/non-alcoholic steatohepatitis patients with advanced liver disease: A german real-world analysis Journal of Hepatology 3
2019 THU-388-Annual healthcare costs double for non-alcoholic fatty liver disease/non-alcoholic steatohepatitis patients who progress to advanced liver disease: A multivariable analysis of German real-world data Journal of Hepatology 3

Data source: OpenAlex API